Champions Oncology Shares Outstanding 2006-2020 | CSBR

Champions Oncology shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Champions Oncology Annual Shares Outstanding
(Millions of Shares)
2019 14
2018 11
2017 11
2016 9
2015 6
2014 6
2013 4
2012 4
2011 3
2010 3
2009 3
2008 3
2007 2
2006 1
2005 1
Champions Oncology Quarterly Shares Outstanding
(Millions of Shares)
2020-01-31 14
2019-10-31 13
2019-07-31 12
2019-04-30 14
2019-01-31 12
2018-10-31 14
2018-07-31 13
2018-04-30 11
2018-01-31 11
2017-10-31 11
2017-07-31 11
2017-04-30 11
2017-01-31 11
2016-10-31 11
2016-07-31 10
2016-04-30 9
2016-01-31 9
2015-10-31 9
2015-07-31 9
2015-04-30 6
2015-01-31 6
2014-10-31 6
2014-07-31 6
2014-04-30 6
2014-01-31 6
2013-10-31 6
2013-07-31 6
2013-04-30 4
2013-01-31 4
2012-10-31 4
2012-07-31 4
2012-04-30
2012-01-31 4
2011-10-31 4
2011-07-31 4
2011-04-30 3
2011-01-31 3
2010-10-31 3
2010-07-31 3
2010-04-30 3
2010-01-31 3
2009-10-31 3
2009-07-31 3
2009-04-30 3
2009-01-31 3
2008-10-31 3
2008-07-31 3
2008-04-30 3
2008-01-31 3
2007-10-31 3
2007-07-31 3
2007-04-30 2
2007-01-31 2
2006-10-31 1
2006-07-31 1
2006-04-30 1
2006-01-31 1
2005-10-31 1
2005-07-31 1
2005-04-30 1
2005-01-31 1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.109B $0.027B
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.594B 37.23
Takeda Pharmaceutical (TAK) Japan $60.596B 10.62
Astellas Pharma (ALPMY) Japan $32.790B 16.38
Eisai (ESALY) Japan $22.308B 41.56
UCB SA (UCBJF) Belgium $17.894B 0.00
Merck (MKGAF) Germany $14.993B 19.66
Grifols, S.A (GRFS) Spain $12.898B 16.03
Catalent (CTLT) United States $11.912B 46.05
Neurocrine Biosciences (NBIX) United States $11.164B 51.60
Ionis Pharmaceuticals (IONS) United States $7.863B 41.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.573B 0.00
Orion OYJ (ORINY) Finland $7.459B 33.42
Jazz Pharmaceuticals (JAZZ) Ireland $6.573B 10.52
United Therapeutics (UTHR) United States $5.061B 9.59
Evotec AG (EVTCY) Germany $4.045B 65.24
Nektar Therapeutics (NKTR) United States $3.953B 0.00
ChemoCentryx (CCXI) United States $3.735B 0.00
Hypermarcas (HYPMY) Brazil $3.692B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $3.368B 367.67
FibroGen (FGEN) United States $3.180B 0.00
PTC Therapeutics (PTCT) United States $3.137B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.642B 10.86
Sage Therapeutics (SAGE) United States $1.941B 0.00
Pacira BioSciences (PCRX) United States $1.875B 38.37
USANA Health Sciences (USNA) United States $1.768B 18.13
Xencor (XNCR) United States $1.767B 0.00
Corcept Therapeutics (CORT) United States $1.747B 17.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.726B 0.00
Heron Therapeutics (HRTX) United States $1.670B 0.00
Zogenix (ZGNX) United States $1.605B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.575B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.555B 11.90
Akebia Therapeutics (AKBA) United States $1.499B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.449B 15.61
Portola Pharmaceuticals (PTLA) United States $1.401B 0.00
Karyopharm Therapeutics (KPTI) United States $1.375B 0.00
Tilray (TLRY) Canada $1.295B 0.00
Translate Bio (TBIO) United States $1.273B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.131B 0.00
Indivior (INVVY) United States $1.069B 13.27
Enanta Pharmaceuticals (ENTA) United States $1.032B 46.07
Endo (ENDP) Ireland $0.898B 1.39
ImmunoGen (IMGN) United States $0.837B 0.00
Collegium Pharmaceutical (COLL) United States $0.796B 0.00
Molecular Templates (MTEM) United States $0.705B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.694B 0.00
Aerie Pharmaceuticals (AERI) United States $0.661B 0.00
Ardelyx (ARDX) United States $0.640B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.542B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.538B 0.00
Harpoon Therapeutics (HARP) United States $0.515B 0.00
Siga Technologies (SIGA) United States $0.493B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Organogenesis Holdings (ORGO) United States $0.489B 0.00
Trillium Therapeutics (TRIL) Canada $0.477B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.467B 18.26
DURECT (DRRX) United States $0.467B 0.00
Flexion Therapeutics (FLXN) United States $0.449B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.446B 10.77
Calithera Biosciences (CALA) United States $0.409B 0.00
Ocular Therapeutix (OCUL) United States $0.376B 0.00
MEI Pharma (MEIP) United States $0.350B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.346B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
TherapeuticsMD (TXMD) United States $0.318B 0.00
Concert Pharmaceuticals (CNCE) United States $0.305B 0.00
Lannett Co Inc (LCI) United States $0.303B 6.64
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.272B 0.00
Rafael Holdings (RFL) United States $0.257B 0.00
Redhill Biopharma (RDHL) Israel $0.245B 0.00
OptiNose (OPTN) United States $0.213B 0.00
Xeris Pharmaceuticals (XERS) United States $0.201B 0.00
VAXART, INC (VXRT) United States $0.197B 0.00
PROFOUND MEDICL (PROF) Canada $0.196B 0.00
KalVista Pharmaceuticals (KALV) United States $0.194B 0.00
Taiwan Liposome (TLC) Taiwan $0.188B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 24.33
IMV INC (IMV) Canada $0.184B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 4.40
Matinas Biopharma Holdings (MTNB) United States $0.178B 0.00
Aquestive Therapeutics (AQST) United States $0.168B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.129B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.127B 0.00
Altimmune (ALT) United States $0.127B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.121B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.115B 0.00
Recro Pharma (REPH) United States $0.113B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Sundial Growers (SNDL) Canada $0.094B 0.00
Heat Biologics (HTBX) United States $0.094B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Otonomy (OTIC) United States $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
SCYNEXIS (SCYX) United States $0.076B 0.00
CTI BioPharma (CTIC) United States $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.073B 0.00
Onconova Therapeutics (ONTX) United States $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.062B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.82
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.050B 0.00
Natural Alternatives (NAII) United States $0.049B 0.00
IsoRay (ISR) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.00
GTx (ONCT) United States $0.047B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.031B 5.90
AgeX Therapeutics (AGE) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Novan (NOVN) United States $0.019B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Addex Therapeutics (ADXN) Switzerland $0.000B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00